Needham & Company Downgrades Covidien Ltd (COV) to Hold
Tweet
Share
E-mailGet Alerts COV Hot Sheet
Price: $106.71 --0%
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Needham & Company downgraded Covidien Ltd (NYSE: COV) from Buy to Hold given Medtronic's (MDT) pending acquisition of COV,
For an analyst ratings summary and ratings history on Covidien Ltd click here. For more ratings news on Covidien Ltd click here.
Shares of Covidien Ltd closed at $88.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Summit Insights Downgrades Silicon Labs (SLAB) to Hold, 'expect its stock to be an inline performer'
- SL Green Realty (SLG) PT Lowered to $45 at Jefferies
- Citi Downgrades Liberty SiriusXM (LSXMA) to Neutral, 'fairly balanced at prevailing levels'
Create E-mail Alert Related Categories
Analyst Comments, DowngradesRelated Entities
Needham & Company, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
